Kolltan Pharmaceuticals - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Kolltan Pharmaceuticals M&A Summary

Kolltan Pharmaceuticals has acquired 1 company of its own.

Kolltan Pharmaceuticals has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Kolltan Pharmaceuticals Ownership

Who owns Kolltan Pharmaceuticals?

Kolltan Pharmaceuticals is owned by Celldex Therapeutics. It was acquired on November 1, 2016.

Was Kolltan Pharmaceuticals formerly PE-backed?

Yes. Kolltan Pharmaceuticals was formerly owned by 1 private investor.

Kolltan Pharmaceuticals Business Overview

Where is Kolltan Pharmaceuticals headquartered?

Kolltan Pharmaceuticals is headquartered in New Haven, Connecticut.

What sector is Kolltan Pharmaceuticals in?

Kolltan Pharmaceuticals is a life science company.

When was Kolltan Pharmaceuticals founded?

Kolltan Pharmaceuticals was founded in 2007.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1

Kolltan Pharmaceuticals, Inc.

300 George Street, Suite 530,
New Haven, Connecticut 06511
United States,
(203) 773-3000
www.kolltan.com

Kolltan Pharmaceuticals, Inc. is a privately held biopharmaceutical company focused on the discovery and development of novel antibody-based drugs targeting receptor tyrosine kinases (RTKs).


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Xetrios Therapeutics, Inc. 2014-09-09 - Add-on Acquisition
San Diego, California
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) - - -
Total 1 - - -

By Geo

State/Country Buy Value Sell Value
United States 1 - - -
  California 1 - - -
Total 1 - - -

 Subscribe to unlock this and 208,055
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 201K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.